Literature DB >> 31510789

Impaired Regeneration Contributes to Poor Outcomes in Diabetic Peripheral Artery Disease.

Gian Paolo Fadini1,2, Gaia Spinetti3, Marianna Santopaolo4, Paolo Madeddu4.   

Abstract

Diabetes mellitus increases the risk and accelerates the course of peripheral artery disease, making patients more susceptible to ischemic events and infections and delaying tissue healing. Current understanding of pathogenic mechanisms is mainly based on the negative influence of diabetes mellitus on atherosclerotic disease and inflammation. In recent years, the novel concept that diabetes mellitus can impinge on endogenous regenerative processes has been introduced. Diabetes mellitus affects regeneration at the local level, disturbing proper angiogenesis, collateral artery formation, and muscle repair. Recent evidence indicates that an impairment in vascular mural cells, alias pericytes, may participate in diabetic peripheral vasculopathy. Moreover, the bone marrow undergoes a global remodeling, consisting of microvessels and sensory neurons rarefaction and fat accumulation, which creates a hostile microenvironment for resident stem cells. Bone marrow remodeling is also responsible for detrimental systemic effects. In particular, the aid of reparative cells from the bone marrow is compromised: these elements are released in an improper manner and become harmful vectors of inflammatory and antiangiogenic molecules and noncoding RNAs. This new understanding of impaired regeneration is inspiring new therapeutic options for the treatment of ischemic complications in people with diabetes mellitus.

Entities:  

Keywords:  bone marrow; humans; ischemia; regeneration; stem cells

Mesh:

Year:  2019        PMID: 31510789     DOI: 10.1161/ATVBAHA.119.312863

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

Review 1.  Autologous Immune Cell-Based Regenerative Therapies to Treat Vasculogenic Erectile Dysfunction: Is the Immuno-Centric Revolution Ready for the Prime Time?

Authors:  Michela Bonanni; Laura Rehak; Gianluca Massaro; Daniela Benedetto; Andrea Matteucci; Giulio Russo; Francesco Esperto; Massimo Federici; Alessandro Mauriello; Giuseppe Massimo Sangiorgi
Journal:  Biomedicines       Date:  2022-05-08

Review 2.  Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy.

Authors:  Y Gu; A Rampin; V V Alvino; G Spinetti; P Madeddu
Journal:  Curr Diab Rep       Date:  2021-03-02       Impact factor: 4.810

Review 3.  Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses.

Authors:  Hao Wu; Vikram Norton; Kui Cui; Bo Zhu; Sudarshan Bhattacharjee; Yao Wei Lu; Beibei Wang; Dan Shan; Scott Wong; Yunzhou Dong; Siu-Lung Chan; Douglas Cowan; Jian Xu; Diane R Bielenberg; Changcheng Zhou; Hong Chen
Journal:  Front Cardiovasc Med       Date:  2022-02-17

Review 4.  The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration-A Narrative Review.

Authors:  Laura Rehak; Laura Giurato; Marco Meloni; Andrea Panunzi; Giada Maria Manti; Luigi Uccioli
Journal:  J Clin Med       Date:  2022-02-08       Impact factor: 4.241

5.  Hyaluronic Acid Facilitates Angiogenesis of Endothelial Colony Forming Cell Combining With Mesenchymal Stem Cell via CD44/ MicroRNA-139-5p Pathway.

Authors:  Yufang Luo; Fang Liang; Xinxing Wan; Shengping Liu; Lanfang Fu; Jiake Mo; Xubiao Meng; Zhaohui Mo
Journal:  Front Bioeng Biotechnol       Date:  2022-03-08

Review 6.  Practical Considerations for Translating Mesenchymal Stromal Cell-Derived Extracellular Vesicles from Bench to Bed.

Authors:  Pauline Po Yee Lui; Yung Tim Leung
Journal:  Pharmaceutics       Date:  2022-08-12       Impact factor: 6.525

Review 7.  Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review).

Authors:  Alessandra Magenta; Maria Cristina Florio; Massimo Ruggeri; Sergio Furgiuele
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

8.  Coadministration of endothelial and smooth muscle cells derived from human induced pluripotent stem cells as a therapy for critical limb ischemia.

Authors:  Jin Ju Park; Yang Woo Kwon; Jeong Won Kim; Gyu Tae Park; Jung Won Yoon; Ye Seul Kim; Da Sol Kim; Sang Mo Kwon; Sun Sik Bae; Kinarm Ko; Chang-Seok Kim; Jae Ho Kim
Journal:  Stem Cells Transl Med       Date:  2020-11-11       Impact factor: 6.940

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.